Neuroglee Health has extended its partnership with the US’ Mayo Clinic to offer dementia and cognitive care, providing support for patients and their care partners.
This partnership builds on their existing work with the Neuroglee Connect solution, which draws upon the Healthy Action to Benefit Independence & Thinking (HABIT) programme’s principles to help maintain cognitive function and independence in individuals with mild cognitive impairment.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
People struggling with dementia and cognitive impairment are eligible for Neuroglee’s longitudinal virtual care programme, which is provided by a specialised team, including licensed social workers and advanced practice nurses, under the supervision of neurologists and geriatric psychiatrists.
The programme offers 24/7 high-touch, wraparound support, focusing on the whole person and emphasising the continuity of in-home care and hospital use avoidance.
Neuroglee’s solutions are designed to improve patient outcomes and experiences while controlling costs.
Care teams engage in symptom management, testing and diagnosis, and remote monitoring while providing support to care partners throughout the dementia care journey.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNeuroglee founder and CEO Aniket Singh Rajput said: “Neuroglee’s clinically proven, technology-enabled care model builds upon Mayo Clinic’s expertise to provide long-term, individualised care that supports both patients and care partners at home.”
The collaboration is in line with Neuroglee’s selection for the Center for Medicare & Medicaid Innovation’s Guiding an Improved Dementia Experience (GUIDE) model, aiming to deliver dementia care to beneficiaries of Medicare.
Patients eligible for the GUIDE will be enrolled across Mayo Clinic locations and partner hubs without incurring any extra charges to the patient or their family.
The average yearly expenditure of Medicare for dementia patients is $22,000, nearly triple the cost for members without dementia or Alzheimer’s.
Neuroglee’s care model has the potential to save more than $6,300 per member annually via longitudinal care and early detection, addressing high-cost drivers and adapting to the patient’s cognitive stage.
